ACM Research (ACMR) Cash & Equivalents (2016 - 2026)

ACM Research (ACMR) has reported Cash & Equivalents for 11 consecutive years, with $872.3 million the latest figure, recorded in Q1 2026.

• Cash & Equivalents for Q1 2026 came in at $872.3 million, up 90.77% year-over-year; the trailing twelve-month figure through Mar 2026 was $872.3 million (up 90.77% YoY), and the FY2025 annual result was $757.4 million, up 85.88% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $872.3 million, up from $757.4 million in the prior quarter.
• The five-year high for Cash & Equivalents was $1.1 billion in Q3 2025, with the low at $182.1 million in Q4 2023.
• A 5-year average of $415.3 million and a median of $333.5 million in 2024 frame the typical range for Cash & Equivalents.
• The widest YoY moves for Cash & Equivalents: up 421.22% in 2022, down 55.92% in 2022.
• ACM Research's Cash & Equivalents stood at $248.0 million in 2022, then retreated by 26.56% to $182.1 million in 2023, then jumped by 123.76% to $407.4 million in 2024, then surged by 85.88% to $757.4 million in 2025, then advanced by 15.17% to $872.3 million in 2026.
• The last three Cash & Equivalents figures came in at $872.3 million (Q1 2026), $757.4 million (Q4 2025), and $1.1 billion (Q3 2025), per Business Quant data.